Greg Michael Delgoffe, PhD: The Problem with Chemo, Radiation and Surgery

Years Funded: 2017-2019

Metabolic Reprogramming of Tumor-Specific T Cells for Immunotherapy
At the University of Pittsburgh Department of Immunology (Pittsburgh, PA), Greg Michael Delgoffe, PhD, and his team are metabolically reprogramming T cells to make them more robust and fit to fight cancer for longer periods of time.

Read More

Join the Alliance

  • This field is for validation purposes and should be left unchanged.